Q4 2024 Treace Medical Concepts Inc Earnings Call Transcript
Key Points
- Treace Medical Concepts Inc (TMCI) reported a 10.4% revenue growth in Q4 2024, reaching $68.7 million, which was at the top end of their preliminary results.
- The company has a growing base of over 3,100 surgeon customers, which provides a ready audience for their expanding suite of technologies.
- TMCI's Lapiplasty system has treated over 120,000 patients since 2015 and is the dollar share leader in the US bunion market.
- The company introduced several new products, including the nanoplasty and percuplasty systems, which are designed to make minimally invasive osteotomies more accessible to surgeons.
- TMCI expects a positive impact from the increased reimbursement for CPT code 28,297, associated with Lapiplasty procedures, effective January 2025.
- Gross margin decreased slightly to 80.7% in Q4 2024 from 81.6% in Q4 2023, due to a product mix shift and increased inventory provisions.
- The company reported a net loss of $0.5 million in Q4 2024, although this was an improvement from a $6.3 million loss in Q4 2023.
- There is a potential risk of Lapiplasty cannibalization with the introduction of new osteotomy products.
- Q1 2025 is expected to be a challenging quarter due to tough year-over-year comparisons, with anticipated low single-digit growth.
- Operating expenses increased to $224 million for the full year 2024, reflecting higher stock-based compensation and investments in product innovation.
Welcome to the Trece Medical concepts, fourth quarter of 2024 earnings conference call.
(Operator Instructions)
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Vivian Cervantes, Investor relations, Gil Martin Group. Please go ahead.
Thank you. Good afternoon, everyone, and welcome to our fourth quarter 2024 earnings conference call. Participating from the company today will be John Tree, Chief Executive Officer, and Mark Hare, Chief Financial Officer. During the call, John will offer commentary on our commercial activities, followed by Mark for a review of our fourth quarter financial results released after market closed today.
We will host a question and answer session following our prepared remarks. Our press release can be found in the investor relations section of our website at investors.tree.com. This call is being recorded and will be archived in the investor section of our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
